Results 31 to 40 of about 2,444,578 (297)

Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines

mSphere, 2022
Predictions of vaccine efficacy against Neisseria meningitidis serogroup B (NmB) disease are hindered by antigenic variability, limiting the representativeness of individual NmB isolates.
Alessandro Muzzi, Margherita Bodini, Nadav Topaz, Vega Masignani, Kumaran Vadivelu, Henju Marjuki, Xin Wang, Laura Serino, Duccio Medini   +8 more
doaj   +1 more source

Preventable diseases: seminar focus on health complications of early marriage, respiratory distress and vaccinations [PDF]

, 2022
It is a known fact that preventable diseases are illnesses, or deaths that could be stopped from occurring. As a part of the ongoing Ph.D. program undertaken by the current and pioneer students in the Novena University, Ogume, different research topics ...
Bello, Umar, Esegbue, Peter, Odoko, Joseph O., Ahmed, Abdullahi, Akuirene, Omatseye A., Moyegbone, John E., Garba, Ahmed, Abdul-Baqi, Magaji, Kio, Franklin E., Ofili, C. Charles, Mijinyawa, Ibrahim, Agege, Emmanuel A., Nwose, Ezekiel U.   +12 more
core   +1 more source

Introducing hepatitis B virus vaccine into the Expanded Programme on Immunization in Bangladesh: a proposed method to evaluate whether the existing infrastructure has the capacity. [PDF]

, 2005
To determine whether the existing Expanded Programme on Immunization (EPI) in Bangladesh has the capacity to introduce the hepatitis B virus (HBV) vaccine, this study was carried out in all the nine health facilities, which maintain a cold-chain, in ...
Fox-Rushby, Julia, Trama, Annalisa, Walker, Damian   +2 more
core   +4 more sources

Vaccination strategies for the prevention of meningococcal disease [PDF]

Human Vaccines & Immunotherapeutics, 2018
Routine prophylactic vaccination and mass vaccination strategies have been used to control both endemic and epidemic disease caused by Neisseria meningitidis globally. This review discusses real-world examples of these vaccination strategies, their implementation, and outcomes of these efforts, with the overall goal of providing insights on how to ...
Scott Vuocolo, Paul Balmer, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson, John L. Perez, Laura J. York   +6 more
openaire   +3 more sources

Antenatal pertussis vaccine effectiveness in England remains high post COVID-19

Journal of Infection
Summary: Objectives: In 2024, pertussis peaked at nearly 15,000 confirmed cases in England leading to the declaration of a national public health incident. Infants aged under 3 months had the highest incidence, with eleven deaths in 2024.
Jemma L. Walker, Sonia Ribeiro, David Litt, Tara Patel, Emma Heymer, Sharif Ismail, Gayatri Amirthalingam, Nick Andrews, Helen Campbell   +8 more
doaj   +1 more source

Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR [PDF]

, 2015
Background and Aims Healthcare workers (HCW) have an increased risk of exposure to infectious diseases and are a potential source of infections for their patients.
Nouanthong, Phonethipsavanh, Black, A., Hübschen, Judith M, Muller, Claude P, Vilivong, Keooudomphone, Souvannaso, Chanthasone   +5 more
core   +1 more source

Vaccine effectiveness against mild and severe covid-19 in pregnant individuals and their infants in England: test negative case-control study

BMJ Medicine
Objective To estimate real world vaccine effectiveness against symptomatic disease and hospital admission with the delta and omicron variants of the SARS-CoV-2 virus in pregnant individuals, and to estimate the protection conferred by previous infection ...
Shamez Ladhani, Nick Andrews, Mary Ramsay, Julia Stowe, Jamie Lopez Bernal, Freja C M Kirsebom, Anna A Mensah, Helen Julia Campbell   +7 more
doaj   +1 more source

Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan. [PDF]

, 2011
BACKGROUND: Hib vaccine has gradually been introduced into more and more countries during the past two decades, partly due to GAVI Alliance support to low-income countries.
Tursunova Dilorom, Ulla K. Griffiths, Shimanovich, Veronika, Hajjeh, Rana, Clark Andrew, Hajjeh Rana, Tursunova, Dilorom, Ulla K Griffiths, Karen Edmond, Mosina, Liudmila, Lucia Kim, Mosina Liudmila, Irina Glinskaya, Veronika Shimanovich, Liudmila Mosina, Edmond Karen, Griffiths, Ulla K, Glinskaya Irina, Rana Hajjeh, Clark, Andrew, Dilorom Tursunova, Shimanovich Veronika, Kim, Lucia, Glinskaya, Irina, Kim Lucia, Edmond, Karen, Andrew Clark, Griffiths Ulla K.   +27 more
core   +2 more sources

New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. [PDF]

, 2012
As more new and improved vaccines become available, decisions on which to adopt into routine programmes become more frequent and complex. This qualitative study aimed to explore processes of national decision-making around new vaccine adoption and to ...
Chavez, E, Biellik, R, Konate, M, Molla, M, Mounier-Jack, S, Griffiths, UK, Burchett, HED, Ongolo-Zogo, P, Uddin, J, Wakasiaka, S, Mills, A, Sarma, H, Gilson, L, Kitaw, Y   +13 more
core   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

FEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang, Ruslana Romaniuk, Hristo L. Svilenov   +2 more
wiley   +1 more source